Role of Axillary Lymph Node Dissection for Residual MACROMETASTASES After NEOADJUVANT Chemotherapy in Patients With HER2+ and Triple Negative Breast Cancer: The OPBC-11/MACRONAC Study
Clinical trial NCT07546695 · RECRUITING
Trial details
- NCT number
- NCT07546695
- Sponsor
- University Hospital, Basel, Switzerland
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2026-02-01
- Primary completion
- 2027-12-01
- Enrollment
- 600
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.